Tweet
8 ounces of 100% Pomegranate juice per day will decrease inflammation everywhere and prevent prostate and breast cancer. This is just one study of hundreds on the powerful benefits of pomegranates. Even hard core anti juice advocates are saying that pomegranate juice(PJ) is the only juice ok to drink. If youre controlling your insulin spikes, you can drink one ounce per hour until you have consumed 8 ounces to avoid the high glycemic effect. I try to take a swig of PJ every hour or so. That way I have a constant supply of PJ going into my system. Its amazing how much it helps. Well worth the investment. Probably about 10 bucks a week. I replaced sugar drinks with water and now spend that money on PJ
Nutr Rev. 2010 Feb;68(2):122-8.
Pomegranate and breast cancer: possible mechanisms of prevention.
Sturgeon SR, Ronnenberg AG.
Department of Public Health, School of Public Health and Health Sciences, University of Massachusetts-Amherst, Amherst, MA 01003, USA. ssturgeon@schoolph.umass.edu
Abstract
Several mechanistic studies in cell culture and mouse models suggest possible estrogen receptor-mediated and non-estrogen receptor-mediated benefits of pomegranate juice with respect to breast cancer risk. These studies demonstrate that various constituents of pomegranates can inhibit aromatase and 17beta-hydroxysteroid dehydrogenase enzymes or have antiestrogenic activity. Additional large, well-controlled human studies are warranted to elucidate the effects of pomegranate juice intake on serum hormone levels. Clarifying the effects of pomegranate constituents on key hormones known to be involved in breast cancer could result in important information for consumers and shed further light on the impact of diet on breast cancer risk.
Nutr Rev. 2010 Feb;68(2):122-8.
Pomegranate and breast cancer: possible mechanisms of prevention.
Sturgeon SR, Ronnenberg AG.
Department of Public Health, School of Public Health and Health Sciences, University of Massachusetts-Amherst, Amherst, MA 01003, USA. ssturgeon@schoolph.umass.edu
Abstract
Several mechanistic studies in cell culture and mouse models suggest possible estrogen receptor-mediated and non-estrogen receptor-mediated benefits of pomegranate juice with respect to breast cancer risk. These studies demonstrate that various constituents of pomegranates can inhibit aromatase and 17beta-hydroxysteroid dehydrogenase enzymes or have antiestrogenic activity. Additional large, well-controlled human studies are warranted to elucidate the effects of pomegranate juice intake on serum hormone levels. Clarifying the effects of pomegranate constituents on key hormones known to be involved in breast cancer could result in important information for consumers and shed further light on the impact of diet on breast cancer risk.
Comment